BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 17197041)

  • 21. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
    Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
    Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The study about immune response to Balb/c mice inoculated with hepatitis B virus DNA vaccine pCI/S2S].
    He X; Zhao LS; Zhou TY; He F; Jiang N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):945-8. PubMed ID: 18095592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
    Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.
    Xu HB; Xu W; Chu YW; Wang Y; Xiong S
    Immunol Lett; 2005 Jul; 99(2):186-92. PubMed ID: 16009269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody.
    Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A
    Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?
    Liu Z; Luo K; He H; Hou J
    J Viral Hepat; 2005 Mar; 12(2):146-53. PubMed ID: 15720529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens.
    Musacchio A; Rodriguez EG; Herrera AM; Quintana D; Muzio V
    Biochem Biophys Res Commun; 2001 Mar; 282(2):442-6. PubMed ID: 11401479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses.
    Chen L; Shao HJ; Su YB
    Int Immunopharmacol; 2004 Mar; 4(3):403-9. PubMed ID: 15037217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HBV DNA vaccination with electroporation enhances significantly the specific cell-mediated immune response in mice against HBV protein vaccine consisting of S-PreS1 fusion particles].
    Chen H; Zhang LL; Tan WJ; Deng Y; Wang W; Yin X; Wen B; Guan J; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Apr; 24(2):94-7. PubMed ID: 21110423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
    Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
    Xing YP; Huang ZH; Wang SX; Cai J; Li J; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):338-40. PubMed ID: 15225426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral and cellular immune responses to HBV in the blood donors].
    Yang YL; Huang ZH; Cai XB; Cai J; Ma GM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):404-6. PubMed ID: 22482413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.